About Clarivate JCR-based Journal Impact Factors 2025
The Journal Impact Factor is a journal-level bibliometric indicator published by Clarivate in Journal Citation Reports (JCR). It is often abbreviated as JIF; JIF is not a separate impact factor, but simply the abbreviation for Journal Impact Factor.
The 2025 Journal Impact Factor provides a journal-level indication of citation activity. It should be interpreted within the journal’s subject area and together with other information, rather than used as a stand-alone judgment of research quality.
On this website, you can explore Journal Impact Factor records presented as Clarivate JCR-based data, together with the five-year Impact Factor, JCR quartile (Q1–Q4), JCR category rank, publisher details and journal identifiers. Verify important submission or evaluation decisions in the official Clarivate Journal Citation Reports.
Browse journal metrics
Showing records 7,361–7,370 of 20,480
| Rank | Journal | ISSN / eISSN | JCR Impact Factor | 5-Year Impact Factor | JCR Quartile | JCR Category Rank | Publisher |
|---|---|---|---|---|---|---|---|
| 7,030 |
Obesity Research & Clinical Practice OBES RES CLIN PRACT |
1871-403X 1878-0318 |
2.300 | 3.100 | Q3 | 71/112 | ELSEVIER SCI LTD |
| 7,030 |
OECOLOGIA OECOLOGIA |
0029-8549 1432-1939 |
2.300 | 2.800 | Q2 | 95/200 | SPRINGER |
| 7,030 |
Online Learning ONLINE LEARN |
2472-5749 2472-5730 |
2.300 | 3.700 | Q1 | 155/756 | ONLINE LEARNING CONSORTIUM |
| 7,030 |
OPEC Energy Review OPEC ENERGY REV |
1753-0229 1753-0237 |
2.300 | 2.100 | Q2 | 175/617 | WILEY |
| 7,030 |
Open Access Rheumatology-Research and Reviews OPEN ACCESS RHEUMATO |
1179-156X 1179-156X |
2.300 | 2.200 | Q3 | 30/58 | DOVE MEDICAL PRESS LTD |
| 7,030 |
Orthopedic Research and Reviews ORTHOP RES REV |
N/A 1179-1462 |
2.300 | 2.500 | Q2 | 46/139 | DOVE MEDICAL PRESS LTD |
| 7,030 |
PALAEONTOLOGY PALAEONTOLOGY |
0031-0239 1475-4983 |
2.300 | 2.700 | Q1 | May-56 | WILEY |
| 7,030 |
PAPERS IN REGIONAL SCIENCE PAP REG SCI |
1056-8190 1435-5957 |
2.300 | 2.700 | Q1 | 43/173 | ELSEVIER SCI LTD |
| 7,030 |
Particles PARTICLES-BASEL |
N/A 2571-712X |
2.300 | 1.800 | Q2 | 41/84 | MDPI |
| 7,030 |
PATHOLOGY & ONCOLOGY RESEARCH PATHOL ONCOL RES |
1219-4956 1532-2807 |
2.300 | 2.300 | Q2 | 40/90 | FRONTIERS MEDIA SA |